Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duration of maintenance immunosuppression after remission in ANCA-associated vasculitis
ISRCTN13739474Phase 4Completed
- Sponsor
- European Vasculitis Society
- Start
- Sep 1998
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 4, randomised, open-label trial of azathioprine and prednisolone in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) (2 arms), sponsored by European Vasculitis Society. Primary endpoint: Rate of vasculitis relapse. Started Sep 1998; status: completed.
02
Drugs
azathioprineprednisolone
03
Conditions
anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on ISRCTN13739474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13739474.